Dysphagia in patients with erosive esophagitis: prevalence, severity, and response to proton pump inhibitor treatment

Clin Gastroenterol Hepatol. 2004 Aug;2(8):665-8. doi: 10.1016/s1542-3565(04)00289-7.

Abstract

Background & aims: Dysphagia is considered an alarm symptom, raising the question of stricture or malignancy. We sought to determine the prevalence and severity of dysphagia in patients with uncomplicated erosive esophagitis and its response to therapy.

Methods: A total of 11,945 patients with endoscopically confirmed erosive esophagitis (Los Angeles grades A-D) participated in 5 double-blind, randomized, clinical trials evaluating the efficacy of up to 8 weeks of treatment with either once-daily esomeprazole 40 mg (n = 5068), esomeprazole 20 mg (n = 1243), omeprazole 20 mg (n = 3018), or lansoprazole 30 mg (n = 2616). The severity of dysphagia (4-point scale) was rated at baseline and at week 4. Esophagitis was classified as mild (grade A or B) or severe (grade C or D).

Results: At baseline, 4449 of 11,945 patients (37%) had dysphagia-43% of patients with severe esophagitis, and 35% of patients with mild esophagitis (odds ratio, 1.39; 95% confidence interval, 1.27-1.51, P < 0.001). Dysphagia resolved in 83% of patients after 4 weeks of proton pump inhibitor (PPI) treatment. Resolution of dysphagia was associated with a mean healing rate of 90% across all treatments. Seventeen percent of patients reported persistent dysphagia, and in these patients the healing rates were decreased significantly (mean 72%; P < 0.0001).

Conclusions: Dysphagia is common in patients with erosive esophagitis but is not a reliable clinical predictor of severe erosive esophagitis. Dysphagia resolved with PPI therapy in most cases, but persistent dysphagia may indicate failed healing.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Ulcer Agents / therapeutic use
  • Deglutition Disorders / diagnosis
  • Deglutition Disorders / drug therapy*
  • Deglutition Disorders / epidemiology
  • Deglutition Disorders / etiology
  • Esophagitis, Peptic / complications
  • Esophagitis, Peptic / diagnosis
  • Esophagitis, Peptic / drug therapy*
  • Esophagitis, Peptic / epidemiology
  • Esophagoscopy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Proton Pumps / therapeutic use
  • Randomized Controlled Trials as Topic
  • Severity of Illness Index
  • Treatment Outcome
  • Wound Healing / drug effects

Substances

  • Anti-Ulcer Agents
  • Proton Pumps